Adequate competitive position benefiting from the well-recognized Blue Cross Blue Shield brand, diversified products, and very profitable nationally ranked specialty products division Market leadership in all key segments despite recent market disruption associated with the University of Pittsburgh Medical Center (UPMC) commercial contract termination Negative operating performance within peer group, due in part to concessionary pricing to maintain market share in the Western and Central Pennsylvania markets Limited geographic diversity in key health plan operations that span Delaware, Pennsylvania, and West Virginia Very strong capital adequacy as measured by our risk-based capital model Moderate risk position due to strategic investments in physician groups and capital-intensive clinical assets used to deliver healthcare Well-balanced investment portfolio consisting of high-credit-quality and well-diversified asset
